DiscoverAuthor in the Room™ InterviewsJAMA: 2012-08-22, Vol. 308, No. 8, Author in the Room™ Audio Interview
JAMA: 2012-08-22, Vol. 308, No. 8, Author in the Room™ Audio Interview

JAMA: 2012-08-22, Vol. 308, No. 8, Author in the Room™ Audio Interview

Update: 2012-09-21
Share

Description

Interview with Philip Greenland, MD, author of Comparison of Novel Risk Markers for Improvement in Cardiovascular Risk Assessment in Intermediate-Risk Individuals. Summary Points:



  • In comparison with other competing biomarkers and risk factors, coronary artery calcium (CAC) is currently the most potent risk marker of subclinical coronary heart disease (CHD).

  • CAC was shown in several observational studies to improve the prediction of risk beyond traditional risk factors.

  • In this JAMA paper, CAC outperformed various competing risk assessment markers among asymptomatic people at intermediate risk for CHD. Whether CAC should be used in routine clinical practice, however, is still a matter of personal opinion or further research.

Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

JAMA: 2012-08-22, Vol. 308, No. 8, Author in the Room™ Audio Interview

JAMA: 2012-08-22, Vol. 308, No. 8, Author in the Room™ Audio Interview